News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
136,498 Results
Type
Article (4370)
Company Profile (95)
Press Release (132028)
Multimedia
Podcasts (4)
Webinars (7)
Section
Business (42102)
Career Advice (212)
Deals (6164)
Drug Delivery (15)
Drug Development (17426)
Employer Resources (18)
FDA (1495)
Job Trends (2790)
News (66249)
Policy (3659)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (294)
Accelerated approval (8)
Adcomms (1)
Allergies (32)
Alliances (11504)
ALS (53)
Alzheimer's disease (432)
Antibody-drug conjugate (ADC) (100)
Approvals (1578)
Artificial intelligence (104)
Autoimmune disease (61)
Automation (12)
Bankruptcy (38)
Best Places to Work (2249)
BIOSECURE Act (14)
Biosimilars (25)
Biotechnology (86)
Bladder cancer (44)
Brain cancer (13)
Breast cancer (189)
Cancer (1347)
Cardiovascular disease (50)
Career advice (204)
Career pathing (5)
CAR-T (124)
Cell therapy (316)
Cervical cancer (9)
Clinical research (15412)
Collaboration (562)
Compensation (280)
Complete response letters (5)
COVID-19 (443)
CRISPR (25)
C-suite (364)
Cystic fibrosis (45)
Data (1940)
Depression (20)
Diabetes (104)
Diagnostics (751)
Digital health (1)
Diversity, equity & inclusion (8)
Drug discovery (92)
Drug pricing (9)
Drug shortages (2)
Duchenne muscular dystrophy (50)
Earnings (13364)
Editorial (5)
Employer resources (18)
Events (26349)
Executive appointments (381)
FDA (2186)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (14)
Funding (478)
Gene editing (54)
Generative AI (12)
Gene therapy (169)
GLP-1 (164)
Government (363)
Guidances (71)
Healthcare (1533)
HIV (8)
Huntington's disease (12)
IgA nephropathy (40)
Immunology and inflammation (68)
Immuno-oncology (13)
Indications (23)
Infectious disease (499)
Inflammatory bowel disease (76)
Inflation Reduction Act (1)
Influenza (34)
Intellectual property (79)
Interviews (19)
IPO (2968)
IRA (4)
Job creations (668)
Job search strategy (186)
JPM (3)
Kidney cancer (3)
Labor market (16)
Layoffs (42)
Leadership (2)
Legal (642)
Liver cancer (16)
Longevity (2)
Lung cancer (126)
Lymphoma (145)
Machine learning (15)
Management (4)
Manufacturing (243)
MASH (19)
Medical device (407)
Medtech (409)
Mergers & acquisitions (3535)
Metabolic disorders (226)
Multiple sclerosis (54)
NASH (1)
Neurodegenerative disease (81)
Neuropsychiatric disorders (15)
Neuroscience (760)
Neurotech (1)
NextGen: Class of 2026 (860)
Non-profit (279)
Now hiring (7)
Obesity (96)
Opinion (41)
Ovarian cancer (68)
Pain (43)
Pancreatic cancer (74)
Parkinson's disease (104)
Partnered (6)
Patents (134)
Patient recruitment (157)
Peanut (17)
People (17141)
Pharmaceutical (8)
Phase 1 (6088)
Phase 2 (7375)
Phase 3 (3789)
Pipeline (1459)
Policy (33)
Postmarket research (209)
Preclinical (2630)
Press Release (51)
Prostate cancer (48)
Psychedelics (5)
Radiopharmaceuticals (51)
Rare diseases (168)
Real estate (1461)
Recruiting (10)
Regulatory (3435)
Reports (15)
Research institute (311)
Resumes & cover letters (20)
Rett syndrome (9)
RNA editing (4)
RSV (13)
Schizophrenia (17)
Series A (92)
Series B (73)
Service/supplier (2)
Sickle cell disease (24)
Special edition (3)
Spinal muscular atrophy (40)
Sponsored (5)
Startups (991)
State (1)
Stomach cancer (2)
Supply chain (22)
Tariffs (9)
The Weekly (4)
Vaccines (124)
Venture capital (19)
Weight loss (41)
Women's health (8)
Worklife (2)
Date
Today (28)
Last 7 days (138)
Last 30 days (537)
Last 365 days (8484)
2026 (812)
2025 (8540)
2024 (9147)
2023 (9882)
2022 (12008)
2021 (12647)
2020 (9863)
2019 (6677)
2018 (5282)
2017 (6073)
2016 (5595)
2015 (6446)
2014 (4924)
2013 (4062)
2012 (4401)
2011 (4873)
2010 (4517)
Location
Africa (144)
Alabama (52)
Alaska (1)
Arizona (35)
Arkansas (2)
Asia (8941)
Australia (2080)
California (3628)
Canada (903)
China (276)
Colorado (72)
Connecticut (127)
Delaware (56)
Europe (19493)
Florida (376)
Georgia (54)
Hawaii (2)
Idaho (11)
Illinois (180)
India (17)
Indiana (196)
Iowa (3)
Japan (106)
Kansas (14)
Kentucky (3)
Louisiana (3)
Maine (2)
Maryland (375)
Massachusetts (2734)
Michigan (97)
Minnesota (157)
Mississippi (1)
Missouri (11)
Montana (10)
Nebraska (2)
Nevada (23)
New Hampshire (7)
New Jersey (679)
New Mexico (6)
New York (800)
North Carolina (442)
North Dakota (5)
Northern California (1780)
Ohio (66)
Oklahoma (7)
Oregon (7)
Pennsylvania (631)
Puerto Rico (8)
Rhode Island (5)
South America (204)
South Carolina (4)
Southern California (1432)
Tennessee (23)
Texas (472)
United States (11424)
Utah (35)
Virginia (27)
Washington D.C. (9)
Washington State (507)
West Virginia (1)
Wisconsin (21)
136,498 Results for "siren biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage
January 29, 2026
·
3 min read
Press Releases
Siren Biotechnology to Showcase Clinical-Stage Momentum at Major 2026 Healthcare Conferences
January 8, 2026
·
2 min read
Business
Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer
Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for Cancer, and Catalent Inc., the leader in enabling the development and supply of better treatments for patients worldwide, entered a strategic partnership to support the development and manufacturing of Siren Biotechnology’s AAV immuno-gene therapies.
May 8, 2024
·
2 min read
Press Releases
Siren Biotechnology Expands Clinical and Scientific Advisory Board with Key Industry Leaders
March 6, 2025
·
4 min read
Genetown
MilliporeSigma Announces Siren Biotechnology as Winner of its North American Advance Biotech Grant
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced that Siren Biotechnology has been selected as the North American winner of its 13th Advance Biotech Grant Program.
June 4, 2024
·
5 min read
Press Releases
Siren Biotechnology to Present Universal AAV Immuno-Gene Therapy Data at the 2025 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
May 13, 2025
·
2 min read
Biotech Bay
Siren Biotechnology Awarded $4M in Grant Funding from the California Institute for Regenerative Medicine (CIRM)
Siren Biotechnology announced that the California Institute for Regenerative Medicine has awarded the company a $4M translational research grant to support the development of novel AAV immuno-gene therapies for cancer.
November 1, 2023
·
2 min read
Press Releases
Siren Biotechnology Reveals SRN-101 as Lead Asset for High-Grade Gliomas with Both Orphan Drug and Rare Pediatric Disease Designations from the FDA
November 18, 2024
·
2 min read
Biotech Bay
Siren Biotechnology Launches to Pioneer Universal AAV Immuno-Gene Therapy™ for Cancer
Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy, a revolutionary new treatment modality for cancer, launched out of stealth concurrent with its first preclinical data presentation at the ASGCT 26th Annual Meeting, taking place in Los Angeles, May 16-20th.
May 17, 2023
·
7 min read
Drug Development
Siren Biotechnology Unveils Preclinical Data for Universal AAV Immuno-Gene Therapy™ for Cancer, a Novel Modality that Combines AAV Gene Therapy and Cytokine Immunotherapy
Siren Biotechnology announced the presentation of preclinical data demonstrating the effect of a novel treatment for cancer, Universal AAV Immuno-Gene Therapy, which combines AAV gene therapy and cytokine immunotherapy into a single modality.
May 17, 2023
·
4 min read
1 of 13,650
Next
